Concurrently with the Notes Offering, Thomas Sandgaard, the Chief Executive Officer of Zynex, is offering 2,000,000 shares of Zynex's common stock in an underwritten public offering (the "Secondary Offering"). Mr. Sandgaard also intends to grant the underwriter a 30-day option to purchase up to an additional 300,000 shares of Zynex's common stock. Zynex will not receive any of the proceeds from the Secondary Offering and Zynex will bear the costs associated with the Secondary Offering, except for underwriting discounts and commissions.